Friday
Jun032011
Canadian Glaucoma Study update (Dr Fred Mikelberg)
GlaucomaDr Mikelberg started by reviewing some of the prior data and also some of the data recently shown at ARVO and that was still in press at the time this talk was given.
Welcome to the Canadian Ophthalmological Society Annual Meeting unofficial blog of topics of interest to glaucoma specialists like myself. This conference is being held in Quebec City from June 26-29, 2010 and therefore you will see many changes to this section of the blog as I update my entries each day. I would like to encourage readers to add their comments to these postings as they appear.
June 26-29, 2010
Highlights of presentations of particular interest to glaucoma specialists
27May2011 Note: I am continuing to edit these articles and ‘publishing’ new entries as I complete each one. WIth the 74th Annual COS Meeting June 9-12, 2011 from Vancouver, I will be sure to finish editing last year’s articles and get ready for the new conference blog.
Entries in risk factors (7)
Wednesday
Jun012011
Ocular blood flow in clinical practice: The World Glaucoma Association Consensus Report (Dr Mark Lesk)
Almost every OBF researcher in the planet answered questions over the internet and then met at ARVO to discuss issues last year. A summary was published in July 2009 by Kugler and answers pretty much any question you might have on blood flow. The issues that were discussed and summarized in today’s talk included: Can we measure OBF meaningfully, does it contribute to glaucoma, does monitoring OBF change the course, what can we do about it.
Monday
May302011
Bayesian estimation of the performance of FDT, HRT & GDx-VCC for glaucoma screening (Dr Gisele Li)
The full topic was the following: Bayesian estimation of the performance of frequency doubling perimetry, confocal scanning laser ophthalmoscopy and GDx variable corneal compensation scanning laser polarimetry for glaucoma screening in the absence of a gold standard for glaucoma diagnosis.
Friday
Apr222011
Comparative study evaluating nocturnal ocular blood flow, BP and IOP in patients w/ OAG and control (Dr Nir Shoham)
The speaker begins with an overview of blood flow risk to visual field loss and how the purpose of this study was to evaluate nocturnal blood flow, blood pressure and intraocular pressure.
Wednesday
Mar162011
Incorporating glaucoma risk factors in clinical trials (Dr Marcelo Nicolela)
In this talk, Dr Nicolela sets out to discuss how to incorporate risk factors into our clinical decisions about patients with glaucoma. He starts by defining risk factors, prognostic factors and modifiable risk factors. We tend to use risk and prognostic factors interchangeably; is there really a difference when it comes to glaucoma as a continuum?